Drugs Made In America Acquisition (DMIIR) Total Current Liabilities (2024 - 2025)
Drugs Made In America Acquisition's (DMIIR) quarterly Total Current Liabilities came in at $300864.0 in Q4 2025, up 18.09% year-on-year from $254783.0 in Q4 2024, and down 55.58% on a QoQ basis from $677345.0 in Q3 2025.
Drugs Made In America Acquisition (DMIIR) Total Current Liabilities (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMIIR) has 2 years of Total Current Liabilities data on file, last reported at $300864.0 in Q4 2025.
- On a quarterly basis, Total Current Liabilities rose 18.09% year-over-year to $300864.0 in Q4 2025; TTM through Dec 2025 was $300864.0, a 18.09% increase from a year earlier, with the FY2025 full-year figure at $300864.0, up 18.09% from the prior year.
- Total Current Liabilities for Q4 2025 stood at $300864.0, down from $677345.0 in the prior quarter.
- Over the last five years, Total Current Liabilities for DMIIR reached as high as $677345.0 in Q3 2025 and fell as low as $254783.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 480.75 Mn | 480.75 Mn | - | 264,756.00 |
| 2 | Agriculture & Natural Solutions Acquisition | 393.29 Mn | 393.29 Mn | - | 17.33 Mn |
| 3 | Berto Acquisition | 314.56 Mn | 314.35 Mn | - | 885,401.00 |
| 4 | GP-Act III Acquisition | 313.66 Mn | 313.66 Mn | - | 634,612.00 |
| 5 | Centurion Acquisition | 311.65 Mn | 311.65 Mn | - | 155,870.00 |
| 6 | Republic Digital Acquisition | 310.50 Mn | 309.63 Mn | - | 113,697.00 |
| 7 | Siddhi Acquisition Corp (Cayman Islands) | 288.97 Mn | 288.97 Mn | - | 175,750.00 |
| 8 | K&F Growth Acquisition | 283.42 Mn | 283.42 Mn | - | 83,264.00 |
| 9 | Bold Eagle Acquisition | 275.29 Mn | 275.29 Mn | - | 239,898.00 |
| 10 | Drugs Made In America Acquisition | - | - | - | 300,864.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 300,864.00 |
| Sep 30, 2025 | 677,345.00 |
| Dec 31, 2024 | 254,783.00 |